News Archive

ERC grants for Michael Potente and Martin Vabulas

September 2012. The European Research Council (ERC) has awarded two of its prestigious ERC Starting Grants to CEF members Michael Potente and Martin Vabulas.

Martin Vabulas	Michael Potente

Set up in 2007 by the EU, the European Research Council is the first pan-European funding organisation for frontier research. It aims to stimulate scientific excellence in Europe by encouraging competition for funding between the very best, creative researchers of any nationality and age. The ERC funds with its starting grants young, early-career top researchers. The substantial funding is awarded based on peer review evaluation. Sole criterium for the selection of successful applications is scientific excellence.

Martin Vabulas will receive 1.37 million Euro over the next 5 years to study the metastability of proteins during tumor metastasis. Michael Potente, whose research is devoted to the analysis of the transcriptional circuits governing the growth, maintenance and regression of blood vessels in development and disease, will receive 1.5 million Euro to expand his research programme. His long-term goal is to map essential genetic regulatory circuits of blood vessel formation and function to illuminate novel therapeutic targets, which might overcome the current limitations of pro- and anti-angiogenic medicine.


Contacts:

Dr. Michael Potente, Institute for Cardiovascular Regeneration, University Hospital, Frankfurt Tel.: +49 69 6301-83985, potente@em.uni-frankfurt.de

Dr. Martin Vabulas, Buchmann Institute for Molecular Life Sciences, Campus Riedberg, Tel.: +49 69 798-42568; vabulas@em.uni-frankfurt.de